SANA Wutah bathi EPS kuartalan Sana Biotechnology, Inc.

Sana Biotechnology operates its own sterile manufacturing facility in California to produce gene products. After analyzing the quarterly EPS growth rate on GURU.Markets, we find that 141.50 forms the current metric value. The company is developing breakthrough hypoimmune stem cells for cancer treatment. The financial model relies on partnership payments and the future sale of organ restoration technologies.

Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Sana Biotechnology, Inc. (SANA): kanggo periode 04.07.2022 - 15.11.2026

Sana Biotechnology (SANA) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:

Rega saham Sana Corp|SANA - Target konsensus

- data kapitalisasi pasar:

Kapitalisasi pasar Sana Bio|SANA - Total Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Aset Bersih saben Siji Saham Sana Biotechnology|SANA - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku sana.com|SANA - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

- rincian bathi lan kelipatan pasar:

SANA - Penghasilan resik perusahaan|Bathi mangsa ngarep Sana Biotechnology|SANA - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Sana Bio|SANA - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Sana Biotechnology, Inc.|SANA - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Sana Biotechnology|SANA - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sana.com|SANA - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Sana Biotechnology

- informasi babagan volume dodolan lan pendapatan:

SANA - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan Sana Biotechnology, Inc.|SANA - Rasio rega marang dodolan|Multiplikator forward rega marang pendapatan Sana Bio|SANA - Wutah pendapatan taun lumaku

Analisis fundamental perusahaan:sana.com - SANA

This metric evaluates operational efficiency through the rate of change in earnings per share. It determines the business's financial margin of safety amid market contraction and declining demand. For Sana Biotechnology (SANA), this calculation is critical due to risks involving ingredient supply chain disruptions and patent disputes. Geopolitical barriers directly impact the profitability of drug development. Analyze these dependencies through quarterly EPS dynamics.

Analisis perusahaan pesaing